1. Home

We will be presenting at the 12th Global Drug Delivery & Formulation Virtual Summit 2021: 17th March 2021

Garry will be presenting an oral presentation, entitled Peptide Nanomaterials: The Future of Biomaterials and Drug Delivery, at 12th Global Drug Delivery & Formulation Virtual Summit 2021: Wednesday 17th March 2021 (11.50am Technology & Innovation case study section).

 

Hopefully you will have to opportunity look see our latest work within drug delivery!

Further details on the conference itself can be found by clicking the link below:

12th Global Drug Delivery & Formulation Virtual Summit 2021

Related News


Advanced Science News Coverage and Advanced Healthcare Materials paper

Our recent research into using peptide hydrogels as long-acting injectable implants for HIV/AIDS drug delivery has be covered by Advanced Science News. This provides an oversight of our most recent publication within Advanced Healthcare Materials. A link to both can be found below: Advanced Science News Advanced Healthcare Materials    

Our EPSRC research selected as case study

Our research into long-acting peptide hydrogel drug delivery implants has been selected as a case study by the EPSRC for their Developing New Therapies Grand Challenge. Thanks to all of those involved in this multidisciplinary project and it’s great to see our work moving forward towards future use in patients. Please find a link to the […]

Latest hydrogel work published in Chemical Communications

Our latest collaborative work on entitled “Tuning the antimicrobial activity of low molecular weight hydrogels using dopamine autoxidation,” has been accepted within Chemical Communications. This work was led by Emily Cross and represents a collaboration with Prof Dave Adams’ Group at the School of Chemistry University of Glasgow and is freely available here. Thanks again […]

Available Research Fellow Position

Research Fellow positions  We are looking for a Research Fellow to support the development of an enzyme-responsive peptide-mimetic hydrogel for the sustained parenteral delivery of antiretroviral drugs for HIV/AIDs. This is an MRC funded project with support available for a one year post (until 30 June 2021). Deadline: Monday 15th June 2020 Salary: £33,797 – […]

Research Group receive Innovate UK ICURe SETsquared Award

We are delighted to be currently taking part in the UKRI Innovate UK ICURe SETsquared Cohort 32 (32-08 / 520268133: £30,000). This programme is allowing us to market validate our peptide hydrogel technology in a variety of applications both within drug delivery and the wider commercial landscape. Our Research Associate Simon Porter is currently undertaking these […]

OUR RESEARCH IS FUNDED BY

Contact Us
  • +44 (0) 28 9097 2273
  • garry.laverty@qub.ac.uk
  • School of Pharmacy, Queen's University Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast, Co. Antrim, N.Ireland. BT97BL
  • Get Directions
Quick Links
Laverty Lab